Elizabeth DeVita-Raeburn is a New York-based writer who specializes in science, health and medicine. She is the author of The Death of Cancer and The Empty Room. She lives in New York City, with her husband, the writer Paul Raeburn, and two sons.

Elizabeth DeVita-Raeburn
From this contributor
The controversy over autism’s most common therapy
Applied behavioral analysis is the most widely used therapy for autism, but some people say its drills and routines are cruel, and its aims misguided.

The controversy over autism’s most common therapy
Explore more from The Transmitter
Tracking single neurons in the human brain reveals new insight into language and other human-specific functions
Better technologies to stably monitor cell populations over long periods of time make it possible to study neural coding and dynamics in the human brain.

Tracking single neurons in the human brain reveals new insight into language and other human-specific functions
Better technologies to stably monitor cell populations over long periods of time make it possible to study neural coding and dynamics in the human brain.
Mitochondrial ‘landscape’ shifts across human brain
Evolutionarily newer regions sport mitochondria with a higher capacity for energy production than older regions, according to the first detailed map of the organelles in a tissue slice, adding to mounting evidence that the brain features a metabolic gradient.

Mitochondrial ‘landscape’ shifts across human brain
Evolutionarily newer regions sport mitochondria with a higher capacity for energy production than older regions, according to the first detailed map of the organelles in a tissue slice, adding to mounting evidence that the brain features a metabolic gradient.
Expediting clinical trials for profound autism: Q&A with Matthew State
Aligning Research to Impact Autism, a new initiative funded by the Sergey Brin Family Foundation, wants to bring basic science discoveries to the clinic faster.

Expediting clinical trials for profound autism: Q&A with Matthew State
Aligning Research to Impact Autism, a new initiative funded by the Sergey Brin Family Foundation, wants to bring basic science discoveries to the clinic faster.